Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07204756

HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Postpartum Cardiovascular Diseases Hypertension Hypertensive Disorder of Pregnancy Infections Toxemia Vascular Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location status: Recruiting

Location contact

Erin Linden

CONTACT

[email protected]

612-625-2273

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • Discharged after delivery at University of Minnesota Medical Center
  • Enrolled into the HOPE-BP Program

Exclusion criteria

  • Ongoing antihypertensive medication use at 2 weeks (time of randomization)
  • Have a medical comorbidity that would not be clinically appropriate to randomize
  • Patients opted out of clinical research

Treatment and study plan

2-Week Home Monitoring

Diagnostic Test

Those who are randomized into the 2-week intervention arm will be unenrolled from the postpartum remote blood pressure monitoring program and therefore will no longer be transmitting twice daily blood pressures for review.

6-Week Home Monitoring

Diagnostic Test

HOPE-BP provides remote monitoring for the 35% of approximately 2,800 annual births at our institution complicated by HDP. Eligible patients enroll at hospital discharge into a 6-week program, submitting blood pressure readings twice daily via Epic's MyChart Care Companion. Participants receive immediate automated feedback, and a dedicated Maternal Fetal Medicine nursing team reviews data daily (Monday-Friday, 8 AM-4 PM), initiating or adjusting antihypertensive therapy as needed.

Primary outcomes

  1. Diastolic Blood Pressure

    Time frame: Week 6

    The primary outcome will be the patient's diastolic blood pressure (DBP) at their 6-week postpartum visit.

Secondary outcomes

  1. Systolic Blood Pressure at 6 weeks post-partum

    Time frame: Week 6

    Patient's systolic blood pressure at their 6-week postpartum visit

  2. 6-Week Post-partum Follow-up Rates

    Time frame: Week 6

    Participants who complete a 6-week post-partum visit / Total participants eligible for a 6-week post-partum visit

  3. Unscheduled OB visit, triage visit, ED visit, or readmission rates

    Time frame: Week 6

  4. Patient Satisfaction Survey responses at 6 weeks

    Time frame: Week 6

    PSS Score, where higher score indicates greater satisfaction

  5. Rate of severe hypertension

    Time frame: Week 6

    defined as systolic blood pressure ≥ 160mmHg and/or DBP ≥ 110 mmHg

  6. Rate of new hypertension diagnosis at 6 weeks postpartum

    Time frame: Week 6

    based on American Heart Association and American College of Cardiology criteria (AHA/ACC)

Study contacts

Contact information is provided by the study sponsor or research team.

Erin Linden

CONTACT

[email protected]

612-625-2273

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Oct 2, 2025
Registry last updated
Jan 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.